chevron icon Twitter logo Facebook logo LinkedIn logo YouTube logo download icon link icon quote icon posted icon clock icon author icon arrow icon arrow icon plus icon Search icon location icon location icon document icon menu icon plus-alt

General overview

Stage of development: Implementation

Policy sector: Health

Date outcomes contract signed: Apr 2021

Start date of service provision: Jul 2021

Anticipated completion date: May 2027

Capital raised (minimum): GBP 1.10m (USD 1.51m)

Max potential outcome payment: GBP 9.77m

Service users: 8k+ individuals


In Northamptonshire, and elsewhere in the UK, the population is growing and getting older, putting increasing pressure on the health and care system. Social prescribing provides an effective and cost-efficient contributory solution. Social prescribing focuses on prevention of ill health and the promotion of positive health and wellbeing (both mental and physical), through community-based services. It addresses the needs of the more vulnerable populations, through a community support model, and it aims to improve both physical and mental health and wellbeing by improving resilience and community support.

Target population

People with long term health conditions and one or more of the following characteristics: High co-morbidity levels; low levels of emotional and mental well-being; high levels of social isolation; frequent attender at GP or hospital; are a carer; have poor English literacy; are obese or inactive and/or have difficult socioeconomic backgrounds.



  • United Kingdom

Service delivery locations

  • Northamptonshire, UK

Outcome metrics

  • Additional complexity payment for people with complex engaged with programme.
  • WEMWS (Warwick-Edinburgh Mental Wellbeing Scale) - improvement after 6 month assessment.
  • WEMWS (Warwick-Edinburgh Mental Wellbeing Scale) - improvement after 12 month assessment
  • Initial Assessment taken place with action plan completed
  • Well Being Star - improvement after 6 month assessment
  • Well Being Star - improvement after 12 month assessment
  • Reduction in GP consultations
Is this information correct?
Do you have more you can add?

Please tell us about it

Get in touch

Important Notice and Disclaimer on INDIGO Data

INDIGO data are shared for research and policy analysis purposes. INDIGO data can be used to support a range of insights, for example, to understand the social outcomes that projects aim to improve, the network of organisations across projects, trends, scales, timelines and summary information. The collaborative system by which we collect, process, and share data is designed to advance data-sharing norms, harmonise data definitions and improve data use. These data are NOT shared for auditing, investment, or legal purposes. Please independently verify any data that you might use in decision making. We provide no guarantees or assurances as to the quality of these data. Data may be inaccurate, incomplete, inconsistent, and/or not current for various reasons: INDIGO is a collaborative and iterative initiative that mostly relies on projects all over the world volunteering to share their data. We have a system for processing information and try to attribute data to named sources, but we do not audit, cross-check, or verify all information provided to us. It takes time and resources to share data, which may not have been included in a project’s budget. Many of the projects are ongoing and timely updates may not be available. Different people may have different interpretations of data items and definitions. Even when data are high quality, interpretation or generalisation to different contexts may not be possible and/or requires additional information and/or expertise. Help us improve our data quality: email us at if you have data on new projects, changes or performance updates on current projects, clarifications or corrections on our data, and/or confidentiality or sensitivity notices. Please also give input via the INDIGO Data Definitions Improvement Tool and INDIGO Feedback Questionnaire.